Page last updated: 2024-11-13

sodium houttuyfonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sodium houttuyfonate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23663544
CHEMBL ID488943
MeSH IDM0448590

Synonyms (14)

Synonym
sodium houttuyfonate
CHEMBL488943
AKOS015962189
83766-73-8
houttuyfonate sodium [who-dd]
497107-87-6
unii-l01u4ri8ij
L01U4RI8IJ ,
houttuynin sodium bisulfite
1-dodecanesulfonic acid, 1-hydroxy-3-oxo-, monosodium salt
sodium 1-hydroxy-3-oxododecane-1-sulfonate
CS-0100971
sodium;1-hydroxy-3-oxododecane-1-sulfonate
HY-N6934

Research Excerpts

Overview

Sodium houttuyfonate (SH) is a chemical compound synthesized by houttuynin and sodium bisulfite. It is a promising anti-Candida TCHMs.

ExcerptReferenceRelevance
"Sodium houttuyfonate (SH) is a derivative of houttuynin in the active oil of Houttuynia cordata, which is stable in nature and has anti-inflammatory activity."( Sodium houttuyfonate enhances the intestinal barrier and attenuates inflammation induced by Salmonella typhimurium through the NF-κB pathway in mice.
Bi, C; Dong, N; Li, Y; Lv, H; Shan, A; Shi, B; Wu, Z; Zhang, L, 2020
)
2.72
"Sodium houttuyfonate (SH) is a promising anti-Candida TCHMs."( Sodium houttuyfonate attenuates dextran sulfate sodium associated colitis precolonized with Candida albicans through inducing β-glucan exposure.
Chen, M; Ge, Y; Liu, J; Ma, K; Shao, J; Wang, C; Wang, T; Wu, D; Yan, G, 2021
)
2.79
"Sodium houttuyfonate (SH) is a chemical compound synthesized by houttuynin and sodium bisulfite. "( Sodium houttuyfonate attenuates neurological defects after traumatic brain injury in mice via inhibiting NLRP3 inflammasomes.
Chen, Y; Li, H; Li, J; Sheng, L; Wang, S; Yao, X; Ye, J; You, H; Zhang, Q, 2021
)
3.51
"Sodium houttuyfonate (SH) is a natural phytoanticipin derivative of houttuynin and has anti-pathogenic effect on P."( Sodium houttuyfonate, a potential phytoanticipin derivative of antibacterial agent, inhibits bacterial attachment and pyocyanine secretion of Pseudomonas aeruginosa by attenuating flagella-mediated swimming motility.
Cheng, H; Shao, J; Sun, Z; Wang, C; Wu, D; Zhu, L; Zhu, X, 2013
)
2.55
"Sodium houttuyfonate (SH) is a derivative of effective component of a Chinese material medica, Houttuynia cordata, which is applied in anti-infection of microorganism. "( [Sodium houttuyfonate inhibits virulence related motility of Pseudomonas aeruginosa].
Cheng, HJ; Duan, QJ; Huang, WF; Wang, CZ; Wu, DQ, 2015
)
2.77
"Sodium houttuyfonate (SH) is an addition compound of sodium bisulfite and houttuynin. "( Effects of sodium houttuyfonate on expression of NF-κB and MCP-1 in membranous glomerulonephritis.
Han, L; Liu, X; Pan, P; Wang, YJ; Yuan, YF; Zhao, M, 2010
)
2.19

Effects

Sodium houttuyfonate (SH) has been found to be mildly anti-pathogenetic against the planktonic and biofilm phenotypes of Pseudomonas aeruginosa.

ExcerptReferenceRelevance
"Sodium houttuyfonate (SH) has been indicated to play an important anti‑inflammatory role. "( Sodium houttuyfonate inhibits LPS‑induced mastitis in mice via the NF‑κB signalling pathway.
Deng, G; Guo, M; Guo, S; Jiang, K; Lin, S; Liu, P; Qiu, C; Wu, H; Yang, C; Zhang, T; Zhao, G, 2019
)
3.4
"Sodium houttuyfonate (SH) has been found to be mildly anti-pathogenetic against the planktonic and biofilm phenotypes of Pseudomonas aeruginosa. "( Sodium houttuyfonate and EDTA-Na₂ in combination effectively inhibits Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans in vitro and in vivo.
Cheng, H; Duan, Q; Huang, W; Li, F; Shao, J; Wu, D, 2015
)
3.3
"Sodium houttuyfonate (SH) has been reported to have antibacterial and anti-inflammatory effects."( Sodium houttuyfonate inhibits LPS-induced inflammatory response via suppressing TLR4/NF-ĸB signaling pathway in bovine mammary epithelial cells.
Fu, Y; Hu, X; Shen, P; Wang, W; Zhang, N, 2017
)
2.62

Actions

Sodium houttuyfonate can inhibit myocardial hypertrophy in mouse and rat models. It could enhance the effect of IMP against pseudomonas aeruginosa biofilms.

ExcerptReferenceRelevance
"Sodium houttuyfonate could enhance the effect of IMP against pseudomonas aeruginosa biofilms. "( [Effect of sodium houttuyfonate in enhancing imipenem's activity against Pseudomonas aeruginosa biofilms].
Cheng, HJ; Chu, CY; Wang, CZ; Yang, M; Zhang, CF, 2014
)
2.23
"Sodium houttuyfonate can inhibit myocardial hypertrophy in mouse and rat models by restricting the activity of the sympathetic nervous system and decreasing the levels of angiotensin II and endothelin-1 in ventricular tissue."( Effect of sodium houttuyfonate on myocardial hypertrophy in mice and rats.
Chen, CX; Gao, JP; Gu, WL; Lü, J; Wang, Y, 2009
)
2.2

Compound-Compound Interactions

Sodium Houttuyfonate combined with Matrine could improve bowel and lung injury.

ExcerptReferenceRelevance
"To explore the immune change of lung injury of Ulcerative colitis (UC) by observing the changes of inherent immunity and adaptive immunity of the lung and bowel in UC rat models after the treatment of Sodium Houttuyfonate combined with Matrine."( The Immune Change of the Lung and Bowel in an Ulcerative Colitis Rat Model and the Protective Effect of Sodium Houttuyfonate Combined With Matrine.
Jing, S; Ni, L; Tu, S; Wang, X; Yang, X; Zhu, L, 2022
)
1.12
"UC rat models were established with the mucous membrane of colon allergize combined with TNBS-alcohol enteroclysis for 1 week and 5 weeks."( The Immune Change of the Lung and Bowel in an Ulcerative Colitis Rat Model and the Protective Effect of Sodium Houttuyfonate Combined With Matrine.
Jing, S; Ni, L; Tu, S; Wang, X; Yang, X; Zhu, L, 2022
)
0.94
" Sodium Houttuyfonate combined with Matrine could improve bowel and lung injury."( The Immune Change of the Lung and Bowel in an Ulcerative Colitis Rat Model and the Protective Effect of Sodium Houttuyfonate Combined With Matrine.
Jing, S; Ni, L; Tu, S; Wang, X; Yang, X; Zhu, L, 2022
)
1.85
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID374532Antimicrobial activity against Staphylococcus aureus isolate 10 after 16 to 18 hrs by agar dilution method2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives.
AID374400Antimicrobial activity against Staphylococcus aureus isolate 1 after 16 to 18 hrs by agar dilution method2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives.
AID374402Antimicrobial activity against Staphylococcus aureus isolate 3 after 16 to 18 hrs by agar dilution method2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives.
AID374530Antimicrobial activity against Staphylococcus aureus isolate 8 after 16 to 18 hrs by agar dilution method2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives.
AID374404Antimicrobial activity against Staphylococcus aureus isolate 5 after 16 to 18 hrs by agar dilution method2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives.
AID374405Antimicrobial activity against Staphylococcus aureus isolate 6 after 16 to 18 hrs by agar dilution method2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives.
AID374403Antimicrobial activity against Staphylococcus aureus isolate 4 after 16 to 18 hrs by agar dilution method2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives.
AID374531Antimicrobial activity against Staphylococcus aureus isolate 9 after 16 to 18 hrs by agar dilution method2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives.
AID374401Antimicrobial activity against Staphylococcus aureus isolate 2 after 16 to 18 hrs by agar dilution method2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives.
AID374529Antimicrobial activity against Staphylococcus aureus isolate 7 after 16 to 18 hrs by agar dilution method2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (18.60)29.6817
2010's23 (53.49)24.3611
2020's12 (27.91)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.70 (24.57)
Research Supply Index3.78 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other42 (97.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]